You are here: Industry Insights > acquisition

News List

Agilent Technologies to acquire multiplicom N.V., a leading european diagnostics company with state- pharmaasia
February 20, 2017
Agilent fortifies its target-enrichment portfolio through its planned acquisition of leading european diagnostics company Multiplicom N.V.
Catalent completes Accucaps acquisition cphi-online
February 20, 2017
Expands softgel development and manufacturing capabilities and capacity.
Cytori Completes Acquisition of Azaya Therapeutics Assets, Initiates Nanomedicine Program firstwordpharma
February 16, 2017
Cytori Therapeutics, Inc. (NASDAQ:CYTX) today announced it has completed its acquisition of assets of privately held Azaya Therapeutics, Inc.
Allergan to acquire US medical technology company Zeltiq for $2.47bn pharmaceutical-technology
February 15, 2017
Ireland-based biopharmaceutical company Allergan has signed an agreement to acquire US-based medical technology company Zeltiq Aesthetics in a deal valued at $2.47bn.
Allergan to Acquire ZELTIQ for $2.47B americanpharmaceuticalreview
February 14, 2017
Allergan and ZELTIQ® Aesthetics, Inc have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 billion, subject to customary adjustments.
Quotient Clinical Acquires SeaView Research contractpharma
February 07, 2017
Expands operations into the U.S.
Patheon acquires Roche’s manufacturing facility in South Carolina, US pharmaceutical-technology
February 06, 2017
Drug development and delivery solutions provider Patheon has completed the acquisition of a manufacturing facility from Roche in Florence, South Carolina, US.
Allergan successfully completes LifeCell acquisition cphi-online
February 06, 2017
Acquisition creates world-class aesthetic and regenerative medicine business in plastic surgery.
Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform firstwordpharma
January 25, 2017
Intrexon Corporation (NYSE: XON) announced that it has entered into a definitive agreement to acquire GenVec, Inc. (NASDAQ: GNVC), a clinical-stage company and pioneer in the development of AdenoVerse™ gene delivery technology.
Amatsigroup Acquires Disposable-Lab contractpharma
January 22, 2017
Enhances capabilities in development services for injectable drug products

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page